Insulin stimulates autophosphorylation of the insulin receptor on multiple tyrosines in three domains: tyrosines 1316 and 1322 in the C-terminal tail, 1146, 1150 and 
INTRODUCTION
The insulin receptor is an insulin-activated tyrosinespecific protein kinase (Kasuga et al., 1982; Ullrich et al., 1985;  for review see Sale, 1988) . Interference in the receptor kinase function either by site-directed mutagenesis or by microinjection of monoclonal antibodies prevents many of the biological responses to insulin, suggesting that the tyrosine kinase plays an important role in insulin signalling (Morgan & Roth, 1987; Ebina et al., 1987; Chou et al., 1987) . Additionally, competing substrates and various inhibitors of the tyrosine kinase inhibit the ability of insulin to activate the insulinreceptor-associated serine kinase ; . The tyrosine kinase catalyses autophosphorylation of the f-subunit of the insulin receptor both in vitro and in vivo on at least six tyrosines clustered in three domains: tyrosines 1316 and 1322 near the Cterminus; tyrosines 1146, 1150 and 1151 in the tyrosine-1150 domain; and tyrosine(s) residing in a third domain, possibly 953, 960 or 972 located near the transmembrane domain (Tornqvist et al., 1987 White et al., 1988; . A further site or sites of tyrosine phosphorylation representing -15 of the phosphate incorporated during autophosphorylation may be present (Tornqvist et al., 1987) . Autophosphorylation activates the tyrosine kinase to phosphorylate exogenous proteins and renders the tyrosine kinase constitutively active even when insulin is subsequently removed from the binding site (Rosen et al., 1983; Yu & Czech, 1984; . Consequently dephosphorylation, and not merely dissociation of insulin, is required to terminate tyrosine kinase activity. Autophosphorylation of the insulin receptor on all three tyrosines in the tyrosine-1150 domain appears to be necessary to activate the tyrosine kinase. In contrast, insulin receptor diphosphorylated in the tyrosine-1150 domain at tyrosines 1146 and 1150 or 1151 had the same activity as non-phosphorylated insulin receptor (White et al., 1988) . Thus the tyrosine-1150 domain seems to function as a regulatory domain. These observations are consistent with results of showing that activation of the tyrosine kinase correlates with the formation of multiply phosphorylated insulin-receptor species.
The state oftyrosine autophosphorylation ofthe insulin receptor and its degree of activation in vivo will depend on the relative activities and phosphorylation-site specificities of the receptor kinase and the phosphotyrosylprotein phosphatase(s) involved in dephosphorylation. The tyrosine kinase phosphorylates tyrosines in the tyrosine-1150 domain most rapidly. Phosphorylation of tyrosines in the C-terminal domain may proceed more slowly, and the tyrosines in the putative juxtamembrane domain may exhibit the slowest rate of phosphorylation White et al., 1988 (King & Sale, 1988a) . Insulin-receptor phosphotyrosyl-protein phosphatase activity was found to be distributed among both particulate and soluble fractions of the cell, with the majority in the former. A similar distribution was obtained with 32P-peptide 1142-1153 of the insulin receptor as substrate (King & Sale, 1 988b) . The major physiologically important phosphotyrosyl-protein phosphatases appear to belong to a novel class of phosphatases distinct from the enzymes which dephosphorylate phospho-seryl and -threonyl residues (King & Sale, 1988a; Tonks et al., 1988b) . In the present work phosphotyrosyl-protein phosphatase activity present in both particulate and soluble fractions of rat liver has been used to study the sequence of dephosphorylation of insulin-receptor autophosphorylation sites. This is important because these fractions contain the native spectrum of phosphotyrosyl-protein phosphatases found in vivo.
EXPERIMENTAL

Materials
Leupeptin and benzamidine were obtained from Sigma Chemical Co., Poole, Dorset, U.K. Soya-bean trypsin inhibitor came from BDH Chemicals, Poole, Dorset, U.K. Cellulose thin-layer plates (20 cm x 20 cm) were from Kodak, Kirkby, Liverpool, U.K. Other chemicals and biochemicals were obtained from sources described in . Preparation of autophosphorylated insulin receptor Insulin receptor was purified from solubilized human placental membranes by affinity chromatography on wheat-germ-agglutinin-agarose as previously described . The receptor was preincubated (approx. 1.5 mg of protein/ml) for 15 min at 22°C in 0.1-1 ml of a solution containing 50 mM-Hepes (pH 7.4), 2 mM-MnCI2, 10 mM-MgCl2, 100 nM-insulin and 0.1 % Triton X-100 (Sale et al., 1986) . Phosphorylation reactions were initiated by addition of [y-32P]ATP (250 ,UM; 8-12 c.p.m./fmol) and were allowed to proceed at 22°C for 30 min. Vanadate was omitted during phosphorylation, as it is a potent inhibitor of insulin-receptor phosphotyrosyl-protein phosphatases (King & Sale, 1988a (King & Sale, 1988a) , by using 50 mM-Hepes buffer (pH 7.4) containing 1 mmdithiothreitol, 5 mM-EDTA, 0.5 mM-EGTA, 1 mM-benzamidine, 1 jug of leupeptin/ml, 1 ug of soya-bean trypsin inhibitor/ml and a 1: 1000 dilution of 2.5 % (v/v) phenylmethanesulphonyl fluoride dissolved in propan-2-ol. The total phosphotyrosyl-protein phosphatase activity recovered in the particulate fractions was approx. 3 times that recovered in the soluble fractions for preparations used in this study. Autophosphorylated insulin receptors (1 mg of protein/ml) were incubated at 30°C in 50 mmHepes (pH 7.4) with particulate or soluble extract (2 mg/ml) and the further addition of 2 ,g of leupeptin/ ml for the indicated times. A small degree of dephosphorylation of autophosphorylated insulin receptor was obtained in the absence of added phosphatase (King & Sale, 1988a) . This endogenous phosphatase activity amounted to < 10 % of the added particulate or soluble phosphatase activity. Dephosphorylation reactions were terminated by mixing 40 ,si portions with 10 dI of SDS sample buffer [312.5 mM-Tris/HCl buffer (pH 7.4) containing 5 % SDS, 75 mg of dithiothreitol/ml and 0.01 % (w/v) Bromophenol Blue (Laemmli, 1970) ], followed by boiling for 2 min. Sucrose was added to a final concentration of 200 mg/ml, and samples were analysed by SDS/polyacrylamide-gel electrophoresis on 4 %-acrylamide stacking and 7.5 %-acrylamide resolving gels (Laemmli, 1970) . Electrophoresis was performed at 20°C for approx. for 2 h in an oven. Then 2 ml of 50 mM-NH4HCO, containing 100 jug of trypsin (treated with tosylphenylalanylchloromethane) was added. The mixture was incubated at 37 'C for 6 h, a further 100 s,g of trypsin was added and incubation continued for a further 18 h. The samples were then freeze-dried.
Peptide mapping
The 32P-labelled tryptic phosphopeptides were dissolved in 20,ul of water and separated on a cellulose thinlayer plate by electrophoresis at 400 V for 4 h at pH 3.5 (pyridine/acetic acid/water, 1: 10: 89, by vol.) in the first dimension and ascending chromatography (pyridine/ acetic acid/butanol/water, 10:3:15:12, by vol.) in the second dimension . For phosphoamino acid analysis and protease-V8 cleavage of tryptic phosphopeptides purified by two-dimensional thin-layer mapping, the peptides were scraped off the plates and eluted by resuspension in either 1 ml of water (for peptides Al, A2, BI and B3) or 1 ml of 33 % (v/v) acetonitrile (for other peptides), followed by centrifugation (10000 g, 2 min) and freeze-drying of the supernatants. Phosphoamino acid analysis was performed by hydrolysing the peptides in 6 M-HCl at 110 'C for 2 h. Phosphoamino acids were separated by electrophoresis on cellulose thin-layer plates at pH 3.5 for 1.5 h at 1 kV . Phosphoamino acid analysis was used to correct for the contribution of [32P]phosphoserine to peptides Cl and Cl'; phosphopeptides Al, A2, BI, B3, C3 and NPI yielded only [32P]phosphotyrosine. Digestion of tryptic peptides with Staphylococcus aureus protease V8 was performed by dissolving the peptides in 50,1 of 50 mM-NH4HCO3, pH 7.8, containing 10,ug of V8 protease/ml and incubating for 16 h at 30 'C. A further 50,l of buffer containing 10,g of V8 protease/ml was then added and incubation continued for a further 5 h. The samples were freeze-dried, and V8 peptides were separated by electrophoresis on cellulose thin-layer plates at 400 V for 2-3 h at pH 3.5 (pyridine/acetic acid/water, 1:10:89, by vol.). Autoradiography of thin-layer plates was performed at -70 'C for 2-7 days, by using Amersham Hyperfilm-MP within cassettes containing Dupont Cronex intensifier screens. 32P associated with phosphopeptides and phosphoamino acids was determined by densitometric scanning of autoradiographs with a Joyce-Loebl Chromoscan 3 instrument, or by scraping the phosphopeptides or phosphoamino acids off the plates and counting for radioactivity in 5 ml of the toluene-based scintillant. The total yield of phosphopeptides from the / subunit was calculated from the 32p present in the fl-subunit and ratio of 32p recovered in phosphopeptides. The amount (fmol) of each phosphopeptide derived from the C-terminal and tyrosine-1150 domains was then calculated by dividing the fmol of 32P by the number of sites phosphorylated. For peptides C3 and Cl' the numbers of sites phosphorylated are not known with certainty, and results are expressed in terms of fmol of 32p. The numbering of insulin-receptor amino acids used in this paper is based on the sequence of the precursor of the human insulin receptor described by Ullrich et al. (1985) .
RESULTS AND DISCUSSION Resolution of tryptic phosphopeptides by twodimensional mapping
To analyse the state of phosphorylation of the insulin receptor, /6 subunits were isolated by SDS/polyacrylamide-gel electrophoresis and subjected to digestion with trypsin followed by two-dimensional thin-layer peptide mapping. A pattern of phosphopeptides broadly similar to that reported by was obtained (Fig. 1) . The identities of most of the major phosphotyrosyl tryptic peptides resolved by two-dimensional thin-layer mapping have been determined by , and these assignments are used in this paper ( ) the identities of phosphotyrosyl tryptic peptides were merely assumed on the basis of comparisons of the two-dimensional maps with those obtained by .
In the present work we have also detected a tryptic phosphopeptide that appears to be the monophosphorylated form of the C-terminal peptide (NP1); this phosphopeptide has not previously been detected. The net charge of this peptide at pH 3.5 would be expected to be + 1.6, which is consistent with the mobility of NPl. NP1 produced by using particulate phosphatase was digested with protease V8 and subjected to electrophoresis at pH 3.5. This yielded a positively charged product (NPlb) that migrated identically with the V8 phosphopeptide, BIb, derived from the C-terminus of BI (calculated net charge at pH 3.5 = + 2.0); mobilities of NPlb and Blb relative to dinitrophenyl-lysine were 4.39 and 4.40 respectively (Fig. 2) . A V8 phosphopeptide corresponding to the position of BI a (expected net charge at pH 3.5 = -1.4), which is derived from the N-terminal portion of Bi, was not detected on digestion of NPI with V8. This indicated that NPI was predominantly phosphorylated on tyrosine 1322. NPl produced by using soluble phosphatase gave similar results. NPl was most evident after partial dephosphorylation, which may account for the failure to detect NPI in previous studies during receptor autophosphorylation (Tornqvist et al., 1987; White et al., 1988; (King & Sale, 1988a insulin receptor (lacking NPI on trypsinolysis) with particulate phosphatase extract for 2-25 min, followed by trypsinolysis of isolated fi subunits and two-dimensional mapping as described in the legend to Fig. 1 . NPI phosphopeptides were scraped off the plates and pooled. BI was isolated from autophosphorylated insulin receptor. The NP1 and B1 were digested with V8, electrophoresed on a thin-layer plate at pH 3.5 and autoradiographed. Arrows mark the position of the original undigested tryptic phosphopeptides, and the open circles mark the position of dinitrophenyl-lysine. Peptides: (a) Bl digested with protease V8, (b) NPI digested with protease V8. The V8 phosphopeptides derived from BI were present in a ratio of 1:0.6 (Bla: Blb), which is similar to that obtained by . Dephosphorylation of triphosphorylated tyrosine-1150 domain. The most striking feature of the time courses of dephosphorylation was the rapid disappearance oftryptic phosphopeptides Al and A2, which were derived from insulin receptor triphosphorylated in the tyrosine-1150 domain. For example, in Fig. 3, with and Cl'. Autophosphorylated insulin receptor was incubated with soluble phosphatase extract (2 mg/ml) and analysed as described in the legend to Fig. 1 maximum of -3000 of the initial amount of B1, this indicates that phosphotyrosyl 1322 is also quite susceptible to dephosphorylation.
General discussion Phosphotyrosyl-protein phosphatase activity in both particulate and soluble fractions from rat liver was shown to elicit a broadly similar pattern of dephosphorylation of insulin-receptor autophosphorylation sites whether analysed by two-dimensional tryptic-peptide mapping or further cleavage of tyrosine-1 150 and C-terminal domain tryptic phosphopeptides with V8 protease. Although the soluble and particulate fractions may each contain more than one species of phosphotyrosyl-protein phosphatase (Tonks et al., 1988 a) , the overall phosphatase specificity of the two fractions towards insulin-receptor autophosphorylation sites was thus similar. This is consistent with the proposal that cytosolic phosphotyrosyl-protein phosphatases have similar membrane-bound counterparts (Tonks et al., 1988 b) .
The triphosphorylated form of the tyrosine 1 50 domain was found to be 3-10-fold more sensitive to dephosphorylation compared with the di-and monophosphorylated forms of the tyrosine-1150 domain or phosphorylation sites in other domains. This may account for the low levels of the triphosphorylated tyrosine-1150 domain detected in insulin-stimulated Fao or H4 rat hepatoma cells (White et al., 1988; , although in two cell lines transfected with insulinreceptor cDNA (CHO.T and NIH 3T3 HIR3.5 cells) insulin stimulated the formation of larger amounts of the triphosphorylated species .
The exquisite sensitivity of the triphosphorylated tyrosine-1 150 domain species to dephosphorylation is of particular significance, as evidence has been obtained that this species plays a critical role in insulin-receptor tyrosine kinase activation (White et al., 1988) . In contrast, insulin receptor diphosphorylated in the tyrosine-1150 domain at tyrosines 1 146 and 150 or 151 had the same activity as non-phosphorylated insulin receptor. Of the diphosphorylated tyrosine-1 150 domain species detected during dephosphorylation, 80-85 o were of this type. Only 15-20 % of the diphosphorylated tyrosine-1150 domain species detected during dephosphorylation were phosphorylated at both the vicinal pair of tyrosines, 1150 and 1151; whether this phosphorylated species is active or inactive has not been studied. Removal of the Cterminal phosphorylation sites by mild trypsinolysis does not affect the phosphotransferase activity of the , subunit, and phosphorylation of sites residing in the putative juxtamembrane domain is not necessary to achieve activation of the insulin-receptor tyrosine kinase (White et al., 1988) . Thus the rapid dephosphorylation of the triphosphorylated tyrosine-1150 domain species by phosphotyrosyl-protein phosphatase may offer a sensitive mechanism for terminating or regulating insulinreceptor tyrosine kinase action and insulin signalling. Attenuation of insulin-receptor tyrosine kinase action may decrease the phosphorylation both of other sites on the insulin receptor as well as other proteins (White et al., 1988) . Moreover, the activities of the phosphotyrosylprotein phosphatases may themselves be controlled.
The possibility arises that non-tyrosine-kinase-activated but phosphorylated insulin-receptor species may be formed in vivo by phosphotyrosyl-protein phosphatase action and may persist after deactivation of the tyrosine kinase. Insulin receptors with a C-terminal truncation that lack autophosphorylation sites 1316 and 1322 show intact tyrosine kinase activity and normal internalization, but are defective in signalling metabolic effects (2-deoxy-D-glucose uptake or glycogen synthase activation) Maegawa et al., 1988) . Thus phosphorylated insulin receptors in which the tyrosine kinase is deactivated may continue to transmit insulin signals.
